Filtering by:
Cancer UpdatesFDA Approves Ayvakit (Avapritinib) for GIST
The US Food and Drug Administration (FDA) has approved Ayvakit (avapritinib) to treat people with advanced cases of gastrointestinal stromal tumor (GIST) that have a certain genetic mutation.
Study: Getting Enough Exercise Lowers Risk of 7 Cancers
Getting recommended amounts of physical activity is linked to a lower risk for 7 cancer types, according to a study from the American Cancer Society, the National Cancer Institute, and the Harvard T.H. Chan School of Public Health.
Facts & Figures 2020 Reports Largest One-year Drop in Cancer Mortality
The death rate from cancer in the US declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop ever recorded, according to annual statistics reporting from the American Cancer Society.
FDA Approves Padcev (Enfortumab vedotin-ejfv) for Bladder Cancer
The US Food and Drug Administration (FDA) has approved a new type of drug for certain people with bladder cancer.
Affordable Care Act Improved Care of Colorectal Cancer in Young Adults
The Affordable Care Act has led to better treatment for young adults diagnosed with colorectal cancer, according to a study from the American Cancer Society and published in the Journal of the National Cancer Institute.